Erasca, Inc. (ERAS)

16.14 -0.12 (-0.74%) USD  |  NASDAQ  |  Sep 04, 13:25
More

Erasca Cash and Short Term Investments (Annual) : 276.08M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for ERAS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 276.08M
December 31, 2024 298.31M
December 31, 2023 312.35M
December 31, 2022 435.62M
Date Value
December 31, 2021 414.48M
December 31, 2020 118.70M
December 31, 2019 50.37M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Revolution Medicines, Inc. 2.026B
Tango Therapeutics, Inc. 343.57M
Cogent Biosciences, Inc. 900.76M
Apogee Therapeutics, Inc. 730.19M
Arrowhead Pharmaceuticals, Inc. 919.37M